Covid has largely dropped out of the headlines, but the virus that causes it is still circulating. We ask what we should know about a new variant of SARS-CoV-2, the state of the Covid pandemic in 2025 ...

COVID-19 has largely dropped out of the headlines, but the virus that causes it is still circulating. We ask what we should know about a new variant of SARS-CoV-2, the state of the COVID-19 pandemic ...

SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), understanding the mechanisms underlying ...

SARS-CoV-2 articles from across Nature Portfolio SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19).

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections.

During the COVID-19 pandemic, scientists learned that the critical path to infection started with the SARS-CoV-2 virus invading the nasal tissues of its victims, then causing millions of deaths by ...

WHO director Dr Tedros Adhanom Ghebreyesus says all hypotheses are on the table, as the organisation works to reinforce ...

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...